Corcept Therapeutics CORT
NASDAQ CORT
$114.03 -1.21 (-1.05%)
As of: Oct 1, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Gross Profit (2012 - 2026)

Updated

Corcept Therapeutics' Gross Profit came in at $252.09 million for Q2 2026, up 32.0% from $191 million a year earlier and up 55.6% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Gross Profit (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Corcept Therapeutics reported Gross Profit of $816.73 million, up 15.9% year-over-year; for FY2025, it came in at $748.43 million, up 12.7% from FY2024.

  • Gross Profit has increased in each of the last 13 years, with a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
  • Going back by year, Gross Profit was $664.16 million in FY2024 (+39.6%), $475.89 million in FY2023 (+20.0%), $396.47 million in FY2022 (+9.9%) and $360.7 million in FY2021 (+3.6%).
  • The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2012.
  • Year-over-year, Gross Profit has increased for 21 consecutive quarters, with growth averaging 21.0% over the last eight quarters.
  • Across the past five years, year-over-year growth in Gross Profit ran from 4.2% in Q4 2022 to 47.3% in Q3 2024.
  • Business Quant data shows CORT's Gross Profit at $162.02 million (Q1 2026), $199.58 million (Q4 2025) and $203.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Corcept Therapeutics 12.46 Bn 11.02 Bn 252.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 252.09 Mn
Mar 31, 2026 162.02 Mn
Dec 31, 2025 199.58 Mn
Sep 30, 2025 203.04 Mn
Jun 30, 2025 191.00 Mn
Mar 31, 2025 154.81 Mn
Dec 31, 2024 178.93 Mn
Sep 30, 2024 179.68 Mn
Jun 30, 2024 161.27 Mn
Mar 31, 2024 144.27 Mn
Dec 31, 2023 133.53 Mn
Sep 30, 2023 121.96 Mn
Jun 30, 2023 116.14 Mn
Mar 31, 2023 104.27 Mn
Dec 31, 2022 101.58 Mn
Sep 30, 2022 100.39 Mn
Jun 30, 2022 102.07 Mn
Mar 31, 2022 92.44 Mn
Dec 31, 2021 97.47 Mn
Sep 30, 2021 94.86 Mn
API Access

Corcept Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CORT&period=max&api_key=YOUR_API_KEY